{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9543231", "DateCompleted": {"Year": "1998", "Month": "05", "Day": "21"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "341", "Issue": "2-3", "PubDate": {"Year": "1998", "Month": "Jan", "Day": "12"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Properties of ginseng saponin inhibition of catecholamine secretion in bovine adrenal chromaffin cells.", "Pagination": {"StartPage": "139", "EndPage": "144", "MedlinePgn": "139-44"}, "Abstract": {"AbstractText": ["To investigate the relationship between the inhibitory effects of ginseng saponins (ginsenosides) on acetylcholine-evoked secretion of catecholamines and the structures of ginsenosides, we examined the effects of ginsenoside-Rg3 and -Rh2, which are panaxadiol saponins, 20(R)- and 20(S)-ginsenoside-Rg2, which are epimers involving the hydroxyl group at C-20 of sapogenin, and other plant saponins on the acetylcholine-evoked secretion of catecholamines from cultured bovine adrenal chromaffin cells. The ginsenoside-Rg3 (1-100 microM) and -Rh2 (10-100 microM) greatly reduced the acetylcholine-evoked secretion in a concentration-dependent manner comparable to that of ginsenoside-Rg2, a panaxatriol saponin, which was the most potent inhibitor in our previous study. 20(R)- and 20(S)-ginsenoside-Rg2 (1-100 microM) similarly reduced the acetylcholine-evoked secretion. In contrast, saikosaponin-a, glycyrrhizin and the cardiac glycosides (100 nM-100 microM), digitoxin and digoxin, had no significant inhibitory effect on catecholamine secretion. Saikosaponin-c (10-100 microM), however, had an inhibitory effect, which was less than that of ginsenoside-Rg2 and -Rg3. These results strongly suggest that the inhibitory effects of ginsenosides on the acetylcholine-evoked secretion of catecholamines from bovine adrenal chromaffin cells are a unique property of ginseng. Further, the relationship between the inhibitory effects and the structures of ginsenosides is discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Iwate Medical University, Morioka, Japan."}], "LastName": "Kudo", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tachikawa", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kashimoto", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Takahashi", "ForeName": "E", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardiac Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Catecholamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Central Nervous System Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Sapogenins"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "227D367Y57", "NameOfSubstance": "ginsenoside Rg3"}, {"RegistryNumber": "5R89LAS235", "NameOfSubstance": "ginsenoside Rg2"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "78214-33-2", "NameOfSubstance": "ginsenoside Rh2"}, {"RegistryNumber": "UR635J3F00", "NameOfSubstance": "saikosaponin D"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cardiac Glycosides"}, {"QualifierName": ["metabolism"], "DescriptorName": "Catecholamines"}, {"QualifierName": [], "DescriptorName": "Cattle"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Central Nervous System Agents"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Chromaffin Cells"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Ginsenosides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sapogenins"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Saponins"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "5", "Day": "23"}, {"Year": "1998", "Month": "5", "Day": "23", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "5", "Day": "23", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9543231", "10.1016/s0014-2999(97)01350-2", "S0014-2999(97)01350-2"]}}]}